ARCHIVE: eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
talentpress releaseinvestorvideoARCHIVE
ARCHIVE: eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCOApril 2, 2025
ARCHIVE: eXoZymes Provides Fourth Quarter and Full Year 2024 Update
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes Provides Fourth Quarter and Full Year 2024 UpdateApril 2, 2025
ARCHIVE: Chemical Engineering: Enzyme engineering breaks out of the cell
press clippingsscienceARCHIVE
ARCHIVE: Chemical Engineering: Enzyme engineering breaks out of the cellApril 1, 2025
ARCHIVE: eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
press releaseIPOinvestorARCHIVE
ARCHIVE: eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025March 26, 2025
ARCHIVE: Fox Business: Interview with Chief Market Strategist, Lou Basenese
investorpress clippingsvideoARCHIVE
ARCHIVE: Fox Business: Interview with Chief Market Strategist, Lou BaseneseMarch 17, 2025
ARCHIVE: Fox Business: Interview with CEO Michael Heltzen
heltzeninvestorpress clippingsvideoARCHIVE
ARCHIVE: Fox Business: Interview with CEO Michael HeltzenMarch 3, 2025
Edgardo Rayo, new member of the Board of Directors at eXoZymes Inc.
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.February 21, 2025
ARCHIVE: Watch eXoZymes' Nasdaq closing bell ceremony
heltzeninvestorvideoARCHIVE
ARCHIVE: Watch eXoZymes' Nasdaq closing bell ceremonyFebruary 20, 2025
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering on Feb 19, 2025
press releaseIPOinvestorARCHIVE
ARCHIVE: Nasdaq Bell Ringing to Commemorate Initial Public OfferingFebruary 19, 2025
ARCHIVE: GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes
press clippingsARCHIVE
ARCHIVE: GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymesFebruary 15, 2025
Previous page
Page 8 of 12
Next page